Investigational Site Number 840408

New York, New York 10032

0 studies enrolling now · 1 studies all time

What they study most

Hypercholesterolemia

Studies at this site

• Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy — Completed